Edition:
United Kingdom

Nevro Corp (NVRO.N)

NVRO.N on New York Stock Exchange

77.89USD
17 Jan 2018
Change (% chg)

$-1.86 (-2.33%)
Prev Close
$79.75
Open
$79.73
Day's High
$80.18
Day's Low
$77.84
Volume
73,912
Avg. Vol
94,005
52-wk High
$99.63
52-wk Low
$65.35

Latest Key Developments (Source: Significant Developments)

Nevro Receives FDA Approval For Senza II
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Nevro Corp ::NEVRO RECEIVES FDA APPROVAL FOR SENZA II SPINAL CORD STIMULATION SYSTEM DELIVERING HF10 THERAPY.  Full Article

Nevro Sees Q4 Revenue $97.4 Million To $97.9 Million
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Nevro Corp ::NEVRO ANNOUNCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FISCAL YEAR 2017 REVENUE.SEES FY 2018 REVENUE $400 MILLION TO $410 MILLION.SEES Q4 REVENUE $97.4 MILLION TO $97.9 MILLION.SEES FY 2017 REVENUE $326.1 MILLION TO $326.6 MILLION.FY2018 REVENUE VIEW $401.7 MILLION -- THOMSON REUTERS I/B/E/S.Q4 REVENUE VIEW $90.4 MILLION -- THOMSON REUTERS I/B/E/S.FY2017 REVENUE VIEW $319.0 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Nevro reports third quarter 2017 financial results
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Nevro Corp :Nevro reports third quarter 2017 financial results.Q3 revenue $82.3 million versus I/B/E/S view $80.5 million.Sees FY 2017 revenue $315 million to $320 million.Nevro Corp - qtrly net loss per share, basic and diluted $0.21‍​.  Full Article

Nevro reports Q2 loss per share $0.31
Monday, 8 Aug 2016 

Nevro Corp : Nevro reports second quarter 2016 financial results . Sees FY 2016 revenue $210 million to $220 million . Updates worldwide revenue guidance for full year 2016 . Nevro Corp qtrly loss per share $0.31 .Q2 revenue $55.4 million versus I/B/E/S view $45.1 million.  Full Article

Nevro announces pricing of public offering of $150 mln convertible senior notes
Wednesday, 8 Jun 2016 

Nevro Corp : Announces pricing of public offering of $150 million convertible senior notes . Says priced its public offering of $150 million aggregate principal amount of 1.75% convertible senior notes due 2021 .Intends to use a portion of net proceeds from this offering and from warrant transactions to fund cost of convertible note hedge transactions.  Full Article

Nevro Corp files for potential mixed shelf offering
Monday, 6 Jun 2016 

Nevro Corp :Nevro Corp files for potential mixed shelf offering, size not disclosed - SEC filing.  Full Article

Nevro says proposed public offering of $125 mln senior notes
Monday, 6 Jun 2016 

Nevro Corp - : Nevro Corp says it intends to offer $125 million aggregate principal amount of convertible senior notes due 2021 . Nevro Corp says notes will mature on june 1, 2021 . Nevro Corp says intends to use a portion of net proceeds and proceeds from warrant transactions to fund cost of convertible note hedge transactions .Nevro announces proposed public offering of $125 million convertible senior notes.  Full Article

Nevro qtrly loss per share $0.33
Monday, 9 May 2016 

Nevro Corp : Qtrly loss per share $0.33 . Nevro reports first quarter 2016 financial results . Q1 revenue $41.7 million versus i/b/e/s view $34.7 million .Sees fy 2016 revenue $175 million to $185 million.  Full Article

Nevro Corp raises FY 2016 worldwide revenue guidance
Monday, 29 Feb 2016 

Nevro Corp:Projects worldwide revenue for FY 2016 to be in the range of $155 to $165 million.This compares to preliminary expectations for Fy 2016 worldwide revenue in the range of $145 to $155 million announced in January 2016.  Full Article

BRIEF-Nevro Receives FDA Approval For Senza II

* NEVRO RECEIVES FDA APPROVAL FOR SENZA II SPINAL CORD STIMULATION SYSTEM DELIVERING HF10 THERAPY Source text for Eikon: Further company coverage: